Results 111 to 120 of about 39,827 (164)

Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer. [PDF]

Oncol Res
Song W, Zhang Y, Shen X, Yu Q, Liu Y, Yu Y, Chen R.   +6 more
europepmc   +1 more source

LncRNA H19: a novel player in the regulation of diabetic kidney disease. [PDF]

Front Endocrinol (Lausanne), 2023
Wu Q, Huang F.
europepmc   +1 more source

Mitophagy suppression via lncRNA H19 silencing: a novel strategy to overcome cisplatin resistance in lung adenocarcinoma. [PDF]

Cell Cycle
Liu MZ, Shao XY, Wu SH, Ning QQ, Zhang C, Du WW, Sun RR, Sun SY, Zhang YW.   +8 more
europepmc   +1 more source

The IL-17 pathway mediated by m6A-modified lncRNA H19: a new mechanism for Jianpi Qingre Tongluo Prescription in repressing inflammation and improving lipid metabolism in gout arthritis. [PDF]

Chin Med
Zhang X, Liu J, Chen X, Ding X, Liu S, Cheng X, Fang D.   +6 more
europepmc   +1 more source

Integrated in-silico and in-vitro analysis of lncRNA H19/miRNA-675/p53 in OSCC: Structural characterization and molecular docking insights. [PDF]

Diagn Pathol
Sekar R, Jayaraman S, Veeraraghavan V, Varadarajan S, Alagumuthu M, Rajendran P, Venkatesalu B.   +6 more
europepmc   +1 more source

Serum lncRNA H19/miR-675 /PPARα expression before middle gestation and their associations with macrosomia risk in singleton pregnancies without gestational diabetes mellitus: a preliminary study. [PDF]

PeerJ
Yu Q, Jin MM, Ding MM, Cheng BW, He XX, Yang XJ.   +5 more
europepmc   +1 more source

METTL3-mediated m6A methylation on lncRNA H19 inhibits intrahepatic cholangiocarcinoma progression through PPARγ downregulation. [PDF]

Int J Biol Sci
Xiao R, Lu X, Huang F, Zhao Y, Jin H, Jia X, Huang B, Wang Y, Chu L.   +8 more
europepmc   +1 more source

Low-frequency electromagnetic fields ameliorate testosterone-induced androgenetic alopecia in mice through LncRNA H19/miR-214-5p/β-catenin signal pathway. [PDF]

Regen Ther
Cheng JH, Chong-You, Hu T, Fang WJ, Niu XM, Du KT.   +5 more
europepmc   +1 more source

Statement of Retraction: lncRNA H19 promotes glioblastoma multiforme development by activating autophagy by sponging miR-491-5p. [PDF]

Bioengineered
europepmc   +1 more source

[Retracted] Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer. [PDF]

Oncol Rep
Lei Y, Guo W, Chen B, Chen L, Gong J, Li W.   +5 more
europepmc   +1 more source